Stay updated on Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Sign up to get notified when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    New revision entries for May 2026 (Revision: v3.5.5) were added to the page's revision history. Older revision markers from May and June 2025 were removed from the history list.
    Difference
    0.1%
    Check dated 2026-06-03T19:42:53.000Z thumbnail image
  2. Check
    13 days ago
    No Change Detected
  3. Check
    20 days ago
    Change Detected
    Summary
    The page's revision badge was updated from v3.5.3 to v3.5.4. This indicates a minor template or system update and does not alter study details or user-facing content.
    Difference
    0.0%
    Check dated 2026-05-20T17:14:26.000Z thumbnail image
  4. Check
    35 days ago
    Change Detected
    Summary
    Added a full bibliographic citation for Gupta et al. on enfortumab vedotin plus pembrolizumab in Future Oncology (2026) with volume, pages, DOI, and online publication date, replacing the previous abbreviated online-ahead-of-print reference in the Publications section. This update clarifies the source details for the related patient-reported outcomes study.
    Difference
    0.0%
    Check dated 2026-05-06T10:28:58.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision: v3.5.3 replaces v3.5.2. This update reflects a version bump for the page's underlying documentation and tooling.
    Difference
    0.0%
    Check dated 2026-04-29T09:17:14.000Z thumbnail image
  6. Check
    49 days ago
    Change Detected
    Summary
    Updated the page revision/version indicator from **v3.5.0** to **v3.5.2**.
    Difference
    0.0%
    Check dated 2026-04-22T05:35:32.000Z thumbnail image
  7. Check
    63 days ago
    Change Detected
    Summary
    Added a new publication citation to the Publications section: How enfortumab vedotin plus pembrolizumab affects the quality of life of people with advanced urothelial cancer: Future Oncol (2026).
    Difference
    0.0%
    Check dated 2026-04-07T22:12:39.000Z thumbnail image

Stay in the know with updates to Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Enfortumab Vedotin Combo vs. Chemo Alone in Urothelial Cancer Clinical Trial page.